Federal Supply Schedule V797D50404

This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 12 to Hema Biologics LLC, a for-profit limited liability company. The contract is for the procurement of pharmaceutical and hematology-related products under FSS Schedule 65 I B, with a ceiling value of $225,000 and a period of performance through September 14, 2026. The contracted products and services encompass a broad range of drugs, pharmaceuticals, and...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Biocon Biologics Inc., a foreign-owned for-profit manufacturer. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under FSS contract 65 I B. No set-asides were used, and it is a multiple award contract. The...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Vantive US Healthcare LLC. The contract provides for drugs, pharmaceuticals, and hematology related products under Federal Supply Schedule 65 IB. With a potential value of $25,000 and a period of performance through August 2024, this multiple-award schedule aims to ensure Veterans receive needed medical supplies and treatments. The...

This Federal Supply Schedule (FSS) contract IDV was awarded by the U.S. Department of Veterans Affairs (VA) to TG Therapeutics Inc., a biopharmaceutical company that develops and markets treatments for blood cancers and autoimmune disorders. The IDV, valued at up to $25,000, is an interim agreement under GSA Schedule 65 IB covering drugs, pharmaceuticals, and hematology-related products. As a Federal Supply Schedule contract, this IDV utilizes a multiple award approach without set-asides. The...

The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...

This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs, has a ceiling value of $300,000.00 and a period of performance through December 14, 2027. The prime contractor is Accord Biopharma, Inc., a for-profit foreign-owned organization. The contract is for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under Schedule 65 I B of the Federal Supply Schedule. The solicitation and resulting...

This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA), is for the procurement of 65IB, Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Shorla Oncology Inc., a for-profit, foreign-owned organization. The contract has a ceiling value of $250,000.00 and a period of performance from August 15, 2024 to August 14, 2029. The contract aims to provide the VA with a range of pharmaceutical and hematology-related products. While no...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Natures Sources LLC. The contract provides pharmaceuticals and drugs under GSA Schedule 65 IB, with a potential value of $427,500. The period of performance is July 1, 2020 through June 30, 2025. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for the VA network. As a multiple-award schedule, it...

This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to procure pharmaceuticals and drugs under GSA Schedule 65 IB. The multiple award contract has a potential value of $750,000 and a period of performance through July 31, 2026. The prime contractor is Myovant Sciences Inc., which will provide drugs, pharmaceuticals, and hematology-related products to support the VA's healthcare services...